Crinetics Approach

SEC Filing Details

Document Details

Form
Filing Date
Feb 11, 2020
Document Date
Feb 7, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Crinetics Pharmaceuticals
Issuer
Crinetics Pharmaceuticals, Inc.
Filer
Vivo Capital Fund VIII, L.P.